Trung Son Pharma

The field of ribonucleic acid (RNA) therapeutics, once considered an unexplored area, is now the most coveted sector in the global biotech industry....

South Korea’s ABL Bio Inc. has signed a $1.06 billion contract to license out its technology for a Parkinson's disease treatment candidate t...

South Korea's CJ Group promoted the group chairman's son Lee Sun-ho to a new executive-level position Monday, paving the way for a third-generatio...

Samsung Biologics Co., a global contract development and manufacturing organization (CDMO), has stepped up its partnerships with global big pharmas ...

Softbank Group founder Masayoshi Son is slated to bet $170 million on Naver Corp.’s metaverse platform. The investment is expected to help Nav...

South Korea’s pharmaceutical conglomerate Celltrion Group has made its very first step in reforming corporate governance structure by merging ...

As concerns rise over a resurgence of the COVID-19 pandemic, the war for talent in South Korea’s pharmaceutical industry is intensifying as th...

South Korea's largest travel platform Yanolja has raised 2 trillion won ($1.7 billion) from the Masayoshi Son-led SoftBank Vision Fund II, marking t...

South Korea will develop its own messenger ribonucleic acid (mRNA) vaccines by next year with plans to annually manufacture 100 million doses from 2...

German biopharmaceutical company CureVac N.V. may choose South Korea as one of its global production bases for the COVID-19 vaccine following Korean...

SoftBank Group founder and CEO Masayoshi Son’s salary more than halved last year, according to the group’s regulatory filing on May 28.T...

Vision Fund, led by billionaire SoftBank founder Masayoshi Son, has decided to invest around $2 billion in South Korea's largest travel platform Yan...

South Korea’s biosimilar and pharmaceutical companies are looking at a growing chance of emerging as a global hub for manufacturing vaccines f...

South Korea is emerging as a global production base for coronavirus vaccines and medicine thanks to its comprehensive production facilities alongside ...

TPG named Sanghoon Lee, an ex-Morgan Stanley executive and elder son of a former Samsung Electronics vice chairman and CEO, as the head of its South K...